Murphy Middleton Hinkle & Parker Inc. lowered its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 42.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 17,052 shares of the company's stock after selling 12,758 shares during the quarter. Procter & Gamble comprises 1.6% of Murphy Middleton Hinkle & Parker Inc.'s investment portfolio, making the stock its 16th biggest holding. Murphy Middleton Hinkle & Parker Inc.'s holdings in Procter & Gamble were worth $2,859,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Acorn Creek Capital LLC lifted its position in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock worth $376,000 after buying an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. grew its holdings in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock valued at $963,000 after purchasing an additional 59 shares during the last quarter. Traveka Wealth LLC increased its position in Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock worth $616,000 after purchasing an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC lifted its stake in Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company's stock valued at $1,507,000 after purchasing an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC grew its stake in shares of Procter & Gamble by 11.2% during the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company's stock worth $105,000 after buying an additional 61 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Insider Activity
In other news, CEO Gary A. Coombe sold 47,847 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company's stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares of the company's stock, valued at approximately $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,439 shares of company stock valued at $13,317,460 in the last three months. Company insiders own 0.18% of the company's stock.
Procter & Gamble Stock Performance
Shares of PG stock traded up $0.85 during trading on Monday, hitting $161.35. The company's stock had a trading volume of 7,218,206 shares, compared to its average volume of 5,628,331. The business has a fifty day moving average of $169.19 and a 200-day moving average of $169.46. The company has a market cap of $379.98 billion, a PE ratio of 27.82, a P/E/G ratio of 3.41 and a beta of 0.45. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business's revenue was down .6% compared to the same quarter last year. During the same period last year, the firm posted $1.83 EPS. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.93 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date is Friday, January 24th. Procter & Gamble's payout ratio is 69.48%.
Wall Street Analyst Weigh In
PG has been the topic of a number of research reports. Evercore ISI boosted their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. UBS Group reduced their target price on shares of Procter & Gamble from $196.00 to $189.00 and set a "buy" rating on the stock in a report on Thursday. Hsbc Global Res upgraded shares of Procter & Gamble to a "strong-buy" rating in a report on Friday, October 4th. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a report on Thursday. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $179.65.
Check Out Our Latest Stock Report on PG
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
